Revisiting the Ventral Medial Nucleus of the Hypothalamus: The Roles of SF-1 Neurons in Energy Homeostasis by Yun-Hee Choi et al.
REVIEW ARTICLE
published: 07 May 2013
doi: 10.3389/fnins.2013.00071
Revisiting the ventral medial nucleus of the hypothalamus:
the roles of SF-1 neurons in energy homeostasis
Yun-Hee Choi 1,2†,Teppei Fujikawa1†, Jiwon Lee1,2, Anne Reuter 3 and KiWoo Kim4*
1 Division of Hypothalamic Research, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA
2 Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX, USA
3 Department of Research Administration, University of Texas Southwestern Medical Center, Dallas, TX, USA
4 Department of Pharmacology, Institute of Lifestyle Medicine and Nuclear Receptor Research Consortium, Wonju College of Medicine, Yonsei University,
Wonju, Korea
Edited by:
Kevin W. Williams, The University of
Texas Southwestern Medical Center,
USA
Reviewed by:




Jason B. Wu, Cedars-Sinai Medical
Center, USA
*Correspondence:
Ki Woo Kim, Yonsei University/Room
401, Wonju College of Medicine,
Department of Pharmacology, 20
Ilsan-ro, Wonju, Gangwon, 220-701,
Korea.
e-mail: kiwoo@yonsei.ac.kr
†Yun-Hee Choi and Teppei Fujikawa
have contributed equally to this work.
Obesity, diabetes, and other metabolic complications are growing concerns for public
health and could lead to detrimental life-threatening conditions. Neurons whose activities
are required for energy and glucose homeostasis are found in a number of hypothalamic
nuclei. In the early twentieth century, the ventral medial nucleus of the hypothalamus
(VMH) was the first site reported to play a prominent role in the regulation of energy
homeostasis through control of food intake and energy expenditure. Recent studies using
sophisticated genetic tools have further highlighted the importance of the VMH and have
extended our understanding of the physiological role of the nucleus in regulation of energy
homeostasis. These genetic studies were preceded by the identification of steroidogenic
factor-1 (SF-1) as a marker of the VMH. This review focuses on the emerging homeosta-
tic roles of the SF-1 neurons in the VMH discovered through the use of genetic models,
particularly highlighting the control of energy, and glucose homeostasis.
Keywords: arcuate nucleus of the hypothalamus, energy homeostasis, glucose homeostasis, knockout, obesity,
steroidogenic factor-1, ventral medial hypothalamic nucleus
INTRODUCTION
Metabolic complications such as obesity, diabetes, and insulin
resistance are growing public health concerns, and their incidences
are continuously increasing. The National Health and Nutrition
Examination Survey (NHANES) found that, from 2009–2010, the
prevalence of overweight (BMI≥ 25) for adults in the United
States was 69.2% and the obesity rate (BMI≥ 30) was 35.9% (Fle-
gal et al., 2012). Imbalances in whole body glucose and insulin
homeostasis are also closely linked to the trend of increased obesity.
Therefore, understanding the molecular and cellular mechanisms
underlying energy balance, glucose, and insulin homeostasis is
critical for developing new strategies for the prevention and treat-
ment of metabolic syndromes including obesity and diabetes.
The hypothalamus, especially the mediobasal hypothalamus, has
been considered a site for whole body homeostatic regulation
including body weight and energy metabolism. Although classical
approaches, such as electronic/chemical lesioning or microinjec-
tion of a compound into a particular site have greatly expanded
our knowledge of the physiological roles of mediobasal hypothal-
amic sites, they have caveats which limit our interpretations from
those studies. For instance, electronic/chemical lesioning of the
VMH likely damages the surrounding regions or the descend-
ing fibers passing through the VMH (Devenport and Balagura,
1971; Gold, 1973). In addition, the microinjection of any com-
pounds into the hypothalamic site is prone to off-target effects
(e.g., leakage of compounds outside of targeted site), which may
compromise the analysis. The development of new genetic tech-
nologies including gene manipulation techniques at the level of
specific neuronal populations can allow us to overcome these
caveats and provides an advanced opportunity to investigate the
neuronal circuitry underlying the mechanism of energy balance in
a specific hypothalamic nucleus. We discuss, in this review, the sig-
nificance of the VMH among many known hypothalamic nuclei
in the regulation of energy and glucose homeostasis, which have
been revealed by genetic approaches. More specifically, we will
focus on steroidogenic factor-1 (SF-1) neurons, a representative
VMH neuronal population, and its metabolic roles.
THE VMH: A HISTORIC LANDMARK OF CENTRAL
REGULATION OF METABOLISM
The hypothalamus, comprised of several distinct nuclei, is a critical
center for homeostatic regulation in the central nervous system.
Among several hypothalamic nuclei, the VMH was the first site
which was recognized as a site for body weight regulation and
energy homeostasis (Hetherington, 1941). Since then, the VMH
has remained site of interest for body weight regulation and glu-
cose homeostasis. (Hetherington, 1941; Rothwell and Stock, 1979;
Minokoshi et al., 1986; Amir, 1990; Dhillon et al., 2006; King, 2006;
Bingham et al., 2008; Klockener et al., 2011). It has been convinc-
ingly shown that VMH lesions directly impact body weight and
food intake mainly through the regulation of the autonomic ner-
vous system (King, 2006). The VMH, a nucleus in the mediobasal
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hypothalamus, is a bilateral cell group with an elliptical shape
located above the median eminence (Figure 1). The cytoarchitec-
ture of theVMH can be distinctively defined by various histological
methods including Nissl staining because the VMH is surrounded
by a cell-poor/fiber (dendrite)-rich zone (Figure 1). The VMH
cytoarchitecture is detectable as early as embryonic day 15 (E15)
(McClellan et al., 2006).
The molecular and cellular mechanisms by which the CNS
including the VMH regulates body weight, food intake, energy,
and glucose homeostasis had been relatively unclear until leptin
and its cognate receptors (LEPRs) were identified (Zhang et al.,
1994; Tartaglia et al., 1995). Although many other hormones such
as insulin have been thought to affect the CNS to regulate energy
and glucose homeostasis, it is safe to say that the identification
of leptin in white adipose tissues and discovery that LEPRs are
mainly expressed in the CNS opened the door for a new era of
study on central regulation of homeostasis. Several studies have
pointed to the arcuate nucleus (ARC) of the hypothalamus, specif-
ically the proopiomelanocortin (POMC)/agouti-related peptide
and neuropeptide Y (AgRP/NPY)-expressing neurons, as the pri-
mary target of leptin and insulin action (Williams et al., 2010;
Gautron et al., 2011; Vianna and Coppari, 2011). Besides juxta-
posed POMC and AgRP neurons in the ARC, the VMH expresses
LEPRs and is a targeted site of leptin and insulin for the regulation
of energy and glucose homeostasis (Elmquist et al., 1998; Scott
et al., 2009). For example, direct application of leptin into the
VMH preferentially increased glucose uptake in skeletal muscle,
heart, and brown adipose tissue (BAT), and this increased glucose
uptake was impaired when the sympathetic nervous system (SNS)
was denervated, suggesting that leptin signaling in the VMH plays
crucial roles in mediation of sympathetic tone from the VMH
to peripheral tissues (Hetherington and Ranson, 1940; Kamohara
et al., 1997; Haque et al., 1999; Minokoshi et al., 1999; Toda et al.,
2009; Kim et al., 2012). Although classic studies had extended our
knowledge on the VMH, recent genetic studies have obliged us to
reconsider and re-highlight the physiological roles of the VMH in
the regulation of energy and glucose homeostasis.
SF-1 IN THE CNS: A MARKER OF THE VMH
The VMH is comprised of various cell types with heterogeneous
gene expression patterns. Many of the genes highly expressed
in the VMH have been identified and their functions have been
FIGURE 1 | SF-1 neurons in the ventromedial hypothalamic nucleus
(VMH). Figures show (A) the location of the hypothalamus in the CNS in a
sagittal section and (B) the location of VMH in a coronal section. (C) (Upper)
Nissle stained coronal section of the hypothalamus and (lower) schematic
diagram of the hypothalamus within the coronal section. (D) Schematic
diagram showing the pattern of genes expressed in the VMH. ARC, the
arcuate nucleus. DMH, dorsomedial hypothalamic nucleus. LHA, lateral
hypothalamic area. VMH, ventral medial nucleus of the hypothalamus. BDNF,
brain-derived neurotrophic factor. ERα, estrogen receptor alpha. IR, insulin
receptors. LepR, leptin receptors. SF-1, steroidogenic factor-1. Schematic
diagrams were generated based on data from McClellan et al. (2006) and Yi
et al. (2011).
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studied (McClellan et al., 2006). Among them, cannabinoid recep-
tor 1 (CB1), pituitary adenylate cyclase activating polypeptide
(PACAP), brain-derived neurotrophic factor (BDNF), and cere-
bellin 1 (Cbln1) which are broadly expressed throughout the
VMH (Xu et al., 2003; Segal et al., 2005; Kim et al., 2008, 2009;
Liao et al., 2012). Other genes such as estrogen receptor alpha
(ERα) and progesterone receptor (PR) possess a limited expres-
sion pattern restricted to the ventro-lateral portion of the VMH
(Figure 1) (Musatov et al., 2006, 2007; Kim et al., 2010). One of our
recent studies using laser-capture microdissection revealed VMH-
enriched genes compared to the other hypothalamic regions (Segal
et al., 2005). A similar study by the Ingraham laboratory identified
approximately 200 genes highly enriched in neonatal (postnatal
day 0) mouse VMH tissue, revealing distinct regional patterning in
the newly formed VMH (Kurrasch et al., 2007). Of these identified
genes, SF-1 (NR5A1) is a transcription factor that is required not
only for terminal differentiation of the nucleus, but also for several
VMH-mediated physiological processes including energy home-
ostasis (Majdic et al., 2002; Segal et al., 2005; Kurrasch et al., 2007).
Intriguingly, although various genes are expressed in the VMH, SF-
1 is the only gene which is specifically and exclusively expressed in
the VMH. Indeed, development of SF-1 neuron-specific Cre lines
in which Cre activity is limited to the VMH accelerated the func-
tional understanding of genes expressed in the VMH (Bingham
et al., 2006; Dhillon et al., 2006). A large body of literature now
suggests that SF-1 neurons in the VMH play an important role in
the regulation of energy and glucose metabolism.
SF-1 NEURONS REGULATE ENERGY HOMEOSTASIS: THEIR
ROLE AS THERMOGENIC NEURONS
SF-1 IN THE VMH
As described above, SF-1-expressing neurons (SF-1 neurons),
among the vast heterogeneous neuronal populations in the VMH,
have recently emerged as a representative neuronal population
involved in many aspects of metabolic regulation. Identification of
the transcription factor SF-1 as an important metabolic regulator
was established by the Parker group while studying germline SF-1
KO mice which exhibit neonatal lethality due to adrenal insuffi-
ciency (Majdic et al., 2002). To circumvent the death of SF-1 KO
mice, they transplanted WT adrenal glands into the SF-1 KO ani-
mals. To their surprise, the transplanted SF-1 KO animals exhibited
massive obesity compared to WT counterparts, thus suggesting
that the expression of SF-1 in the VMH plays critical suppres-
sive roles against body weight gain. However, since the VMH of
germline SF-1 KO mice had disrupted cytoarchitecture, the obesity
phenotype in the transplanted animals could be a consequence of
impaired VMH formation rather than SF-1 absence in the nucleus
(Majdic et al., 2002; Davis et al., 2004; Zhao et al., 2008). There-
fore, we generated an alternative mouse model named postnatal
VMH-specific SF-1 KO in which SF-1 is specifically deleted after
completion of VMH development using CamKII-Cre, a postna-
tally expressing Cre line, to delineate the direct metabolic roles
of SF-1 without the confounding developmental side effects (Kim
et al., 2011). The studies using the postnatal VMH-specific SF-
1 KO animals revealed that SF-1 is indeed required for normal
energy homeostasis by modulating energy expenditure specially
in high-fat diet condition (Kim et al., 2011).
MANIPULATION OF GENES IN SF1 NEURONS
Two independent groups generated SF-1-Cre transgenic lines in
which the expression of Cre recombinase is restricted to SF-
1 cells of the VMH, significantly advancing our understanding
of VMH-mediated metabolic regulation (Bingham et al., 2006,
2008; Dhillon et al., 2006). These transgenic mice induce Cre-
recombination in exclusively in the VMH. These lines were used
to target the deletion of the leptin receptor and the insulin recep-
tor in the VMH, providing direct physiological insights on their
roles in the nucleus (Dhillon et al., 2006; Bingham et al., 2008;
Klockener et al., 2011). Deletion of the leptin receptor in SF-1
neurons of the VMH (Sf1-Cre, Leprflox/flox mice) resulted in sim-
ilar effects on body weight regulation observed when the leptin
receptor is removed from POMC neurons (Pomc-Cre, Leprflox/flox
mice) of the ARC (Balthasar et al., 2004; Dhillon et al., 2006).
For example, both KO models significantly gained weight dur-
ing 5–9 weeks of age mainly due to decreased energy expenditure
but the weight gain were bunted afterward, implicating possible
developmental compensatory mechanisms in adulthood in KO
animals (Balthasar et al., 2004; Dhillon et al., 2006). Thus, addi-
tional studies using temporally manageable Cre lines would be
helpful to explore direct metabolic roles of leptin receptor signal-
ing in the VMH without the confounding effects of developmental
compensation.
The first direct evidence for insulin receptor signaling in the
VMH was revealed by the generation of SF-1 neuron-specific
insulin receptor knockout mice (SF-1∆IR mice) (Klockener et al.,
2011). The SF-1∆IR mice exhibited improved glucose metabolism
and resistance to high-fat diet, and, interestingly, increased cellu-
lar activity of POMC neurons. These observations suggest that the
blunted insulin responses in SF-1 neurons in response to high-
fat diet conditions increase excitatory neuronal projections to the
POMC neurons resulting in protection from diet-induced weight
gain. Notably, electrophysiological techniques used by the inves-
tigators revealed that the leptin- and insulin-responsive neurons
are segregated in the SF-1 neurons as they are in POMC neurons
(Williams et al., 2010; Klockener et al., 2011). In addition, reduced
activity of pik3ca (p110α), a catalytic subunit of PI3K, in SF-1 cells
rendered blunted autonomic responses to high calorie food and
reduced leptin action without alteration in glucose and insulin
homeostasis (Xu et al., 2010). Interestingly, specific deletion of a
transcription factor, FOXO1, a downstream effector of PI3K, in
SF-1 neurons results in profound effects on energy homeostasis
together with alterations in glucose and insulin metabolism (Kim
et al., 2012). Specifically, ablation of FOXO1 in SF-1 neurons exhib-
ited lean phenotypes due to increased energy expenditure and
enhanced insulin sensitivity by increment of insulin-stimulated
glucose disposal in cardiac and skeletal muscle. These results
indicate the presence of isoform-specific roles of PI3K in glu-
cose and insulin homeostasis in the SF-1 neurons of the VMH
(Figure 2).
Not surprisingly, investigators also used SF-1-Cre transgenic
mice to examine the metabolic roles of several other genes thought
to be associated with metabolic regulation. Enhanced leptin recep-
tor signaling by removing suppressor of cytokine signaling-3
(SOCS3), a negative regulator of leptin action (Figure 2), from
SF-1 neurons results in minimal effects on body weight but shows
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FIGURE 2 | Intracellular signaling in SF-1 neurons. Leptin binding to
LEPRs induces auto-phosphorylation of LEPRs and phosphorylation of JAK2
(pJAK2), and subsequently these phosphorylated sites and pJAK2 induce
phosphorylation of STAT3 (pSTAT3). pSTAT3 is translocated into the nucleus
and alters the expression of several genes including SOCS3. SOCS3
negatively regulates JAK2 and other phosphorylated sites in LEPRs. Insulin
binding to insulin receptors activates IRS and it activates PI3K. PI3K
phosphorylates PIP2 and produces PIP3. PTEN dephosphorylates PIP3,
thus generating PIP2. A recent study indicates PIP2 directly binds SF-1 in
the nucleus (Blind et al., 2012). PIP3 phosphorylates AKT (pAKT) and pAKT
induces phosphorylation of FOXO1 (pFOXO1) in the nucleus. pFOXO1 is
translocated to the cytosol. FOXO1 directly binds SF-1 and inhibit SF-1
activity. AKT, serine/threonine-specific protein kinase. FOXO1, Forkhead box
protein O1. JAK2, janus kinase 2. IRS, insulin receptor substrate. STAT3,
signal transducer and activator of transcription. PIP2, phosphatidylinositol
(4,5)-bisphosphate. PIP3, phosphatidylinositol (3,4,5)-triphosphate, PTEN,
phosphatase and tensin homolog. P110, p110 catalytic subunit. P85, p85
regulatory subunit. SIRT1, sirtuin 1 or silent mating type information
regulation 2. SF-1, steroidogenic factor-1. SOCS3, suppressor of cytokine
signaling-3.
increased insulin sensitivity (Zhang et al., 2008). Furthermore,
both inhibition and activation studies of SIRT1 in SF-1 neurons,
demonstrated the protective roles of SIRT1 against diet-induced
metabolic imbalance (Ramadori et al., 2011). More recently, we
ablated estrogen signaling specifically in the ventro-lateral por-
tion of the VMH using the SF-1-Cre transgenic mice revealing
that estrogen signaling is required for normal energy expenditure
and abdominal fat homeostasis (Xu et al., 2011).
Interestingly, at this point the aforementioned genetic studies
on SF-1 neurons have argued the idea that the VMH is the center
of satiety, as most of the studies did not report changes in food
intake behavior (Table 1). Of note, SF-1 neurons are represen-
tative population of the VMH, yet SF-1 is not expressed in the
entire nucleus. Thus, non-SF-1 neurons in the VMH may play a
role in the regulation of food intake behavior. Indeed, deletion of
long form 3UTR′ BDNF in the VMH leads to hyperphagia and
obesity in mice (Liao et al., 2012). Moreover, deletion of ERα in
the entire VMH leads to hyperphagia and more profound obe-
sity (Musatov et al., 2007) than that seen when ERα is deleted
only in SF-1 neurons (Xu et al., 2011). Notably, both BDNF and
ERα are abundantly expressed in the ventro-lateral area of the
VMH (Xu et al., 2003; Musatov et al., 2007), where SF-1 is not
expressed in the adult (Cheung et al., 2013). Thus, it seems that
topographically and genetically distinct neurons from SF-1 neu-
rons may regulate food intake behavior. Contrarily, studies on SF-1
neurons support the idea that the VMH is the regulatory cen-
ter of energy expenditure. A common characteristic among mice
bearing genetically engineered gene deletions in SF-1 neurons is a
defect in diet-induced thermogenesis upon high-fat diet feeding
(Table 1). These mice do not exhibit metabolic dysfunction upon
normal chow-diet; however, exposure to high-fat diet induces a
defective ability to adapt to the thermogenic environment (we
defined “HFD-induced phenotype.” Table 1). It is well known
that high-fat diet feeding increases energy expenditure, thus heat
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Table 1 | Gene manipulation specifically in SF-1 neurons affects energy and glucose homeostasis.













- - ? ? ? ? Kim et al. (2011)
HFD ∆ - ? ∆ ? ? ?
SF1
(postnatal)
SD - - - - ∆ (fed and fast in
old ages)
H H
HFD ∆ - H ∆ ∆ (fed and fast) ? ?
LepR SD ∆ - - ∆ - ? ? Dhillon et al. (2006)
HFD ∆ ∆ H ∆ - ? ?
IR SD - - - - - ? ? Klockener et al. (2011)
HFD H H - H - ∆ ∆
PTEN SD ∆ ∆ ? ? ? ? ?
HFD - - ? ? ? ? ?
p110α SD - - - - - - H Xu et al. (2010)
HFD ∆ - H ∆ ? ? ?
FOXO1 SD H - ∆ H H (fed and fast) ∆ ∆ Kim et al. (2012)
HFD H - ∆ H ? ? ?
SOCS3 SD - H H ? H (fed and fast) ∆ ∆ Zhang et al. (2008)
HFD - H H ? H (fed) ∆ ∆
SIRT1 (KO) SD - - - - - ? ? Ramadori et al. (2011)
HFD ∆ - H ∆ ∆ (fed and fast) H ?
SIRT1(OE) SD - - - - - - -
HFD H - ∆ H - ∆ ?
ERα SD - - - - - H (female) ? Xu et al. (2011)
HFD ∆ (female) - H (female) ∆ (female) - ? ?
VGLUT2 SD - ? ? ? H (fast) ? ? Tong et al. (2007)
HFD ∆ ∆ - ∆ ? ? ?
All genes except for SIRT1 were deleted specifically in SF-1 neurons. -, unchanged. ∆, increased. H, decreased. ?, not measured. SD, standard diet. HFD, high-fat
diet. KO, knockout. OE, overexpression. SF-1, steroidogenic factor-1. LepR, leptin receptors. IR, insulin receptors. PTEN, phosphatase and tensin homolog. P110 α,
p110 catalytic subunit alpha. FOXO1, forkhead box protein O1. SOCS3, suppressor of cytokine signaling-3. SIRT1, Sirtuin 1 or silent mating type information regulation
2, homolog 1. ERα, estrogen receptor alpha. VGLUT2, vesicular glutamate transporter 2.
production, which probably helps to avoid excessive body weight
gain. Although none of the studies described above investigated
whether SF-1 neurons regulate thermogenesis/energy expenditure
under other thermogenic environments such as cold exposure or
prolonged exercise, SF-1 neurons may play roles in the regulation
of thermogenesis/energy expenditure under those thermogenic
environments as well. Collectively, although SF-1 neurons do not
represent all neurons within the VMH, the genetic deletion or
overexpression studies completed to date establish that SF-1 neu-
rons in the VMH are essential for normal energy homeostasis,
particular in regulation of thermogenesis/energy expenditure.
COMPARISON TO OTHER HYPOTHALAMIC NEURONS
Some physiological roles (e.g., regulation of food intake and
bodyweight) among POMC, AgRP, SF-1, and other hypothala-
mic neurons likely overlap because those neurons directly and
indirectly communicate with each other within the hypothala-
mus. Indeed, redundant roles should exist to maintain energy
homeostasis which is fundamental for life. Therefore, it is diffi-
cult to explicitly define the distinct roles that different neurons
have in the regulation of energy homeostasis. For instance, dele-
tion of LEPRs either in POMC or SF-1 neurons leads to the same
degree of body weight gain in chow-diet feeding. Nonetheless,
it must be noted that in most cases, mice with a manipulated
gene in POMC or AgRP neurons exhibit metabolic abnormalities
under even chow-diet feeding conditions (Vianna and Coppari,
2011). Meanwhile, as see in Table 1, HFD-induced phenotypes
are prominently observed in mice with a manipulated gene in
SF-1 neurons. Thus one distinct physiological role of SF-1 neu-
rons compared to other hypothalamic neurons is that they may
regulate energy homeostasis to adapt to thermogenic, at least obe-
sogenic, environments. Since a large number of studies indicate
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that induction of thermogenesis may be useful to treat obesity and
eventually obesity-related disease, SF-1 neurons are a potential
target for development of anti-obesity drugs.
SF-1 NEURONS REGULATE GLUCOSE HOMEOSTASIS:
SENSING AND REGULATING GLUCOSE
Besides the important role of SF-1 neurons in the regulation of
energy homeostasis, genetic studies have also illuminated that
SF-1 neurons are critical components of mechanism underpin-
ning glucose homeostasis. While it has been suggested that the
hypothalamus and the VMH have a role in the control of glu-
cose levels and counterregulation, conclusive evidence was lacking
(Himsworth, 1970; Niijima et al., 1988). The first clear evidence
indicating that the VMH is a key glucose-sensing region was estab-
lished about two decades ago (Borg et al., 1994). Borg et al. (1994)
reported that conscious rats with a chemical lesion in the VMH
exhibited impaired glucagon, epinephrine, and norepinephrine
responses against hypoglycemia. In addition, inducing glucopenia
around the VMH using 2-deoxyglucose (a non-metabolizable glu-
cose analog), resulted in an immediate increase in plasma glucose
in association with a marked elevation of glucagon, epinephrine,
and norepinephrine, suggesting that neurons in the VMH play
a critical role in triggering the release of counterregulatory hor-
mones important for defending against hypoglycemia (Borg et al.,
1995). They convincingly established the VMH as a key brain site
for hypoglycemic counterregulation by producing hypoglycemia
only in peripheral tissues (Borg et al., 1997). Combined with
these physiological studies, several electrophysiological studies fur-
ther demonstrated that the VMH contains neurons that directly
respond to glucose (Song and Routh, 2006; Cotero and Routh,
2009).
Tong et al. (2007) recently demonstrated a critical role for
the vesicular glutamate transporter (VGLUT2) in counterregula-
tory action against insulin-induced hypoglycemia specifically in
SF-1 neurons of the VMH. In this study, they generated mice
lacking VGLUT2 selectively in SF-1 neurons to determine the
metabolic roles of the fast-acting neurotransmitter glutamate.
They found that the KO mice (Sf1-Cre;Vglut2flox/flox) were slightly
obese compared to their controls, especially when challenged
with a high-fat diet. Interestingly, the Sf1-Cre;Vglut2flox/flox mice
exhibited impaired glucose homeostasis in the fasted condition
together with blunted counterregulatory responses to insulin-
induced hypoglycemia. Furthermore, when they induced hypo-
glycemia using a hypoglycemic clamp, the Sf1-Cre;Vglut2flox/flox
mice displayed significantly blunted responses of counterregula-
tory hormones including glucagon and epinephrine. This genetic
approach establishes that SF-1 neurons of the VMH are a critical
subset of neurons playing important roles in counterregulation
against hypoglycemia in the brain.
In addition, accumulating evidence has pointed to leptin,
insulin, and their downstream effectors as regulators of glucose
homeostasis in the SF-1 neurons. For example, the restoration of
leptin receptors within the mediobasal hypothalamus of leptin
receptor-mutated Koletsky rat using virus-mediated gene deliv-
ery significantly increased glucose and insulin sensitivity through
SNS activity. This improved sensitivity was blunted by applica-
tion of a PI3K inhibitor, suggesting that the leptin-PI3K-FoxO1
pathway is a potential signaling pathway for glycemic homeostasis
in SF-1 neurons (Keen-Rhinehart et al., 2005; Morton et al., 2005;
Morton and Schwartz, 2011; Kim et al., 2012). Together with the
leptin-PI3K-FoxO1 pathways, a genetic KO study suggested that
the leptin-phosphorylated signal transducer and activator of tran-
scription 3 (pSTAT3) pathway is also associated with glycemic
control in SF-1 neurons of the VMH (Zhang et al., 2008). A
recent report indicated that microinjection of orexin into the
VMH enhances glucose uptake in the skeletal muscle (Shiuchi
et al., 2009). In line with this report, deletion of SIRT1 in SF1 neu-
rons attenuates orexin induced activation of the SF1 neurons, and
this underlies decreased insulin sensitivity in the skeletal muscle
of SF1-neuron-specific SIRT1 KO mice (Ramadori et al., 2011).
Moreover, a recent study identified that the transcriptional pro-
grams of SF-1 are required for the normal glucose homeostasis in
rodents, especially in relatively old age groups (Kim et al., 2012).
Therefore, it is entirely possible that transcriptional networks reg-
ulated by SF-1, pSTAT3, and FoxO1 that are responsible for the
modulation of neuronal activities from or in the VMH might be
crucial for glucose and energy homeostasis. Future studies dis-
secting these complicated networks would be helpful not only to
understand the glycemic homeostasis regulated by the brain but
also to facilitate drug development to possibly treat diabetes.
PERSPECTIVES: NOVEL GENETIC TOOLS FOR
UNDERSTANDING SF-1 NEURONS
Studies using genetically engineered mice have provide more
specific and precise insights by which the hypothalamic neuro-
circuitry regulates energy homeostasis than classical approaches.
However, a major critique of traditional knockout mouse mod-
els is that genetic modifications that occur prenatally may be
affected by developmental plasticity/compensation, especially in
the CNS. This issue has been highlighted by work from Palmiter
and colleagues who have found disparate phenotypes in mice with
prenatal and postnatal ablation of AgRP neurons (Luquet et al.,
2005, 2007; Wu et al., 2008, 2009). Briefly, global knockout of AgRP
neurons does not cause any abnormalities of body weight, food
intake behavior and adiposity (Luquet et al., 2007). Deletion of
AgRP neurons early in development by diphtheria toxin-inducible
system reveals that prenatal deletion of AgRP leads to modest
changes in body weight; however, deletion of AgRP neurons in
adulthood results in severe hypophagia, decreased body weight
and eventually causes death (Luquet et al., 2005). Moreover, it has
been shown that prenatal mice express POMC in multiple hypo-
thalamic lineages, including cells that do not express POMC in
adult mice (Padilla et al., 2010). This developmental issue is of
particular concern in future studies on SF-1 neurons as a recent
report shows that the expression pattern of SF-1 in the CNS dif-
fers between prenatal and adult mice (Cheung et al., 2013). In
this regard, for instance, generating an inducible SF-1-Cre mouse
must be a top priority to avoid a developmental caveat seen in a
conventional SF-1-Cre mouse.
Recent advanced genetic technologies, optogenetic and phar-
macogenetic tools, have been employed to probe the function of
neuronal activities and the neuronal circuits underpinning food
intake and reward behavior (Domingos et al., 2011; Krashes et al.,
2011; Kong et al., 2012). Detailed methodology of optogenics
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and pharmacogenetics are described elsewhere, but briefly these
techniques can allow us to temporally and precisely manipu-
late particular neuronal activities either in vitro or in vivo in
adult rodents. Optogenetic approaches take advantage of genet-
ically engineered photochemical receptors, for instance, Channel-
rhodopsin-2 (ChR2), which is isolated from Chlamydomonas rein-
hardtii1. Particular wavelengths of light (e.g., 480 nm for ChR2)
can stimulate optogenetical receptors and lead to depolariza-
tion (activation) or hyperpolarization (inhibition) of the mem-
brane potential of neuronal cells. Pharmacogenetic tools such
as Designer Receptor Exclusively Activated by Designer Drugs
(DREADD) which is a genetically modified G-coupled protein
receptor, has been developed by Roth and colleagues2. Neurons
expressing DREADD can be specifically activated or inhibited
by an administration of clozapine-N-oxide (CNO). Compared to
optogenetic tools, pharmacogenetic tools can allow us to modu-
late neuronal activity in specific neurons for hours by just a single
administration of CNO (Krashes et al., 2011). These advanced
techniques have great advantages over conventional Cre/loxP tech-
nology. First, we can examine physiological outcomes of “direct”
manipulation of the excitability specific of neurons in vivo in
adult rodents. Second, using these two tools combined with other
pharmacological and neuronal tracing techniques we can now
map the neuronal circuit along with physiological outcomes (Ata-
soy et al., 2012). Yet these advanced technologies have not been
applied to discerning the physiological role of SF-1 neurons and
the neuronal circuit of SF-1 neurons. Specifically, these tech-
nologies may answer many questions: what are the metabolic
outcomes (e.g., alterations in energy expenditure and glucose lev-
els in the blood) of alterations in the membrane potential of SF-1
neurons?; and what neurons connected to SF1 neurons are impor-
tant to regulate energy and glucose homeostasis? Moreover, those
1http://www.stanford.edu/group/dlab/optogenetics/
2http://pdspit3.mml.unc.edu/projects/dreadd/wiki/WikiStart
technologies may unravel the intra-VMH connectome, which is
completely unknown. Those answers undoubtedly will be instru-
mental to design new therapies for obesity and obesity-related
diseases.
SUMMARY
It is now established that the hypothalamus is a major site for the
regulation of metabolic homeostasis in the brain. Disruption of
this homeostasis leads to obesity, diabetes, and other metabolic
complications. Although we have witnessed marked advances in
the field of central regulation of energy and glucose homeostasis
during the past century, the hypothalamic circuitry is far more
complicated and needs to be further investigated. As described
above, because neurons within the hypothalamus communicate
with each other and have redundant physiological roles, it is vir-
tually impossible to clearly determine the division of roles in
energy regulation and glucose homeostasis among hypothalamic
neurons. Nonetheless, it is worthwhile to emphasize that SF-1
neurons play critical roles in the regulation of energy homeosta-
sis to adapt to obesogenic and likely other thermogenic envi-
ronments, than other hypothalamic neurons. Moreover, genetic
studies indicate that SF-1 neurons may mediate the effect of
various hormones including leptin and orexin on glucose metabo-
lism. However, several pieces of knowledge for understanding the
mechanism by which SF-1 neurons regulate energy homeostasis,
particularly in thermogenesis, and glucose homeostasis are miss-
ing. Novel genetic tools, which are described above and will be
developed in the future, will unravel that mechanism and ulti-
mately may lead to the design of new anti-obesity and -diabetes
drugs.
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